Out of stock
Manufacturer: ADO-ADINOS
₹34.00 Inclusive of all taxes
Manufacturer : ADO-ADINOS
Composition : DEXTROSE-50%
Description : DEXTROSE AMPOULE - 50% / 25ML
Route Of Administration : PARENTERAL
Pack : 1

Manufacturer: ADO-ADINOS

Drug Ingredient Information



Information for patients
Drug Information indicated as a source of water and calories.
Drug Alert
Alert Dextrose (hydrous dextrose (hydrous dextrose) ) Injection, USP should not be administered simultaneously with blood through the same administration set because of the possibility of pseudoagglutination or hemolysis. The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutive states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections. Excessive administration of dextrose (hydrous dextrose (hydrous dextrose) ) injections may result in significant hypokalemia. In very low birth weight infants, excessive or rapid administration of dextrose (hydrous dextrose (hydrous dextrose) ) injection may result in increased serum osmolality and possible intracerebral hemorrhage.
Before Consuming the Medicine
Avoid Drug Solutions containing dextrose (hydrous dextrose (hydrous dextrose) ) may be contraindicated in patients with known allergy to corn or corn products.
Drug Special Care Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Dextrose (hydrous dextrose (hydrous dextrose) ) Injection, USP should be used with caution in patients with overt or subclinical diabetes mellitus. Pregnancy Teratogenic Effects Pregnancy Category C Animal reproduction studies have not been conducted with Dextrose Injection, USP. It is also not known whether Dextrose (hydrous dextrose (hydrous dextrose) ) Injection, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Dextrose (hydrous dextrose (hydrous dextrose) ) Injection, USP should be given to a pregnant woman only if clearly needed. Pediatric Use Dextrose (hydrous dextrose (hydrous dextrose) ) is safe and effective for the stated indications in pediatric patients (see INDICATIONS AND USAGE). As reported in the literature, the dosage selection and constant infusion rate of intravenous dextrose (hydrous dextrose (hydrous dextrose) ) must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/ hypoglycemia. Frequent monitoring of serum glucose concentrations is required when dextrose (hydrous dextrose (hydrous dextrose) ) is prescribed to pediatric patients, particularly neonates and low birth weight infants. Geriatric Use Clinical studies of Dextrose (hydrous dextrose (hydrous dextrose) ) Injection, USP did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy. Do not administer unless solution is clear and seal is intact.
Drug Drug Interactions No information provided.
Drug Pregnancy Interaction no data available
Drug Breast feeding Interaction no data available
Drug Machinery Interaction no data available
Drug More Information no data available
How to take the Medicine
Consumption Info no data available
Drug quanitty As directed by a physician. Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. All injections in VIAFLEX plastic containers are intended for intravenous administration using sterile equipment. Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the physician, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced. Do not store solutions containing additives.
Drug Dose no data available
Excess Drug Consumption No information provided.
Forgot Drug Consumption Contact Your doctor
Stop Drug Consumption Do not stop the drug untill your doctor says you to do so.
Possible Side Effects
General Information no data available
Common Drug Side Effects Reactions which may occur because of the injection or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Rare Drug Side Effects no data available
Very Rare Drug Side Effects no data available
Drug Side Effects Symptoms no data available
How to Store the Medicine
How to Store the Medicine Store in a cool and dry place.

Substitute Drugs

Manufacturer: ADO-ADINOS
Write Your Own Review
You're reviewing:DEXTROSE 50% AMPOULE 25ML
Your Rating
More Information
manufacturer ADO-ADINOS